Serdal Korkmaz
7PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 13, 2021
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden
|Sep 01, 2021
Retrospective analysis on efficacy of convalescent plasma in acute respiratory distress syndrome due to COVID-19.Esma Eren, Ayşegül Ulu-Kılıç, Serdal Korkmaz
|May 06, 2021
COVID-19 clinical course and blood groups: Turkish population-based studyMehmet Sinan Dal, Naim Ata, Fevzi Altuntaş
|Oct 22, 2019
Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort StudyMüfide Okay, Tuncay Aslan, Evren Özdemir
|Feb 15, 2019
Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?Serdal Korkmaz, Selahattin Erdem, Ebru Akay
|Nov 08, 2018
Frequent Mutation in the FTL Gene Causing Hyperferritinemia Cataract Syndrome in Turkish Population Is c.-160A>GBurhan Balta, Murat Erdoğan, Aslıhan Kiraz
Pageof 2
Frequent Collaborators
2 joint publications
Fevzi Altuntaş
2 joint publications
Semih Başcı
2 joint publications
Mehmet Sinan Dal
2 joint publications
Tuğçe Nur Yiğenoğlu
2 joint publications
Mehmet Hilmi Doğu
2 joint publications
Sinem Namdaroğlu
1 joint publications
Hatice Terzi
1 joint publications
Meliha Nalçacı
1 joint publications
Aslıhan Kiraz
1 joint publications
Alperen Ağadayı
